Healio

Response to Juvéderm Voluma XC high in midface at 6 months, increased with injection volume

Please provide your email address to receive an email when new articles are posted on . Juvéderm Voluma XC injected into three facial subregions resulted in high responder rates at 6 months, according ...
Medscape

FDA Okays Cheek Volume Filler Juvederm Voluma XC

The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...
Healio

FDA panel recommends Juvéderm Voluma XC for cheek augmentation

Please provide your email address to receive an email when new articles are posted on . “Because there are no permanent adverse reactions or deforming reactions, I think the safety is assured,” Karen ...
Nasdaq

Allergan : FDA Oks Juvéderm VOLUMA XC For Mid-Face Injection Via Cannula

(RTTNews) - Allergan plc (AGN) said that it received U.S. Food and Drug Administration approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula ...